MedPath

Elutia Celebrates First Year | Morningstar

Elutia Inc. celebrates one-year anniversary with FDA approval for EluPro™, 20% sales growth, and 170% shareholder value increase.


Reference News

Elutia Celebrates First Year | Morningstar

Elutia Inc. celebrates one-year anniversary with FDA approval for EluPro™, 20% sales growth, and 170% shareholder value increase.

© Copyright 2025. All Rights Reserved by MedPath